INS and type 2 diabetes mellitus: To address this paucity of research, we performed the current NMA to combine high-quality data from the most updated trials and thus comprehensively compare the effects of SGLT-2i, DPP-4i, GLP-1RA, TZD, Met, AGI and basal insulin in patients with T2DM that was inadequately controlled by SU monotherapy.